Broad microbial biomolecules (PAMPs)

Broad microbial biomolecules is a collective term encompassing a wide array of molecular structures derived from pathogenic and commensal microorganisms. These include Pathogen-Associated Molecular Patterns (PAMPs) such as lipopolysaccharides (LPS) from Gram-negative bacteria, peptidoglycans from Gram-positive bacteria, flagellin, and various forms of microbial nucleic acids (Janeway & Medzhitov, 2002). These biomolecules are essential for the survival or pathogenicity of the microbe and are recognized by the host innate immune system via Pattern Recognition Receptors (PRRs), including Toll-like receptors (TLRs) and NOD-like receptors (NLRs) (Poltorak et al., 1998). In a therapeutic context, these molecules are often the focus of broad-spectrum antimicrobial agents or serve as adjuvants in vaccine formulations to enhance the immune response (Wolf & Cassat, 2019). For instance, antibiotics like polymyxins directly target the lipid A component of LPS to disrupt bacterial membranes, while synthetic analogs are used as immunomodulators to treat cancers or viral infections. However, because the term refers to a heterogeneous group of substances rather than a single protein or receptor, it is not classified as a specific therapeutic target in drug discovery and is considered too broad for precise pharmacological characterization.

Other names

Pathogen-Associated Molecular PatternsPAMPsMicrobe-Associated Molecular PatternsMAMPsMicrobial antigensMicrobial metabolites

Drugs targeting these biomolecules typically act by direct physical binding to disrupt microbial structural integrity or by mimicking these molecules to activate host Pattern Recognition Receptors (PRRs) and stimulate an immune response (Janeway & Medzhitov, 2002; Wolf & Cassat, 2019).